Haikou People's Hospital Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2017
NCT03236636
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Haikou People's Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

xingnaojing (1 trial)

Drugs in Phase 3 Trials (3)

Epimedium (1 trial)

huachansu pian (1 trial)

neuregulin (1 trial)

Drugs in Phase 1 Trials (2)

amphotericin b (fungizone) (1 trial)

denosumab (prolia) (1 trial)

Drugs in Other Trials (1)

montelukast (singulair) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Cerebral Infarction (Phase 4)

Heart Failure (Phase 3)

Heart Failure, Systolic (Phase 3)

Ischemia (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 7